Status:
UNKNOWN
Tolerability of Iron Therapy in Women With AUB
Lead Sponsor:
University of Calgary
Conditions:
Iron Deficiency Anemia
Abnormal Uterine Bleeding
Eligibility:
FEMALE
18-50 years
Brief Summary
Telephone surveys of female patients using liposomally-bound iron and traditional iron sulphate preparations for the management of iron deficiency anemia to determine gastrointestinal tolerability.
Detailed Description
1. Rationale and Background: Abnormal uterine bleeding (AUB) affects women worldwide. In high income countries, heavy menstrual bleeding (a subset of AUB) is the most common cause of iron deficien...
Eligibility Criteria
Inclusion
- Diagnosed with iron deficiency secondary to abnormal uterine bleeding
Exclusion
- Postmenopausal, premenarchal and pregnant women are excluded, as they do not have regular uterine bleeding associated with menses.
Key Trial Info
Start Date :
July 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04915196
Start Date
July 1 2021
End Date
July 1 2022
Last Update
June 7 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.